Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China (Front. Immunol, (2021), 10.3389/fimmu.2021.627844)

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

In the original article, there was a mistake in Table 1 as published. The author identified the calculating errors in the percentage of comorbidity, symptoms, and treatment. The corrected Table 1 appears below.

Cite

CITATION STYLE

APA

Cao, W., Liu, X., Hong, K., Ma, Z., Zhang, Y., Lin, L., … Li, T. (2021, March 22). Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China (Front. Immunol, (2021), 10.3389/fimmu.2021.627844). Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2021.671443

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free